Alignment Healthcare, Inc. (ALHC) intrinsic value & 10-year financials
Alignment Healthcare, Inc. (ALHC) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 8 fiscal years revenue grew 31.8% a year to $3.9B, with an average return on invested capital of 549.3%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $8.28
- Market cap
- $1.6B
- Revenue (FY2025)
- $3.9B
- Revenue growth (8-yr CAGR)
- 31.8%
- ROIC (10-yr avg)
- 549.3%
- Free cash flow (FY2025)
- $113.1M
ALHC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $3.9B | -$724.0K | $0.00 | $113.1M | 0.4% | -41.8% |
| FY2024 | $2.7B | -$128.0M | -$0.67 | -$6.6M | -3.8% | -167.7% |
| FY2023 | $1.8B | -$148.0M | -$0.79 | -$95.2M | -7.1% | -216.4% |
| FY2022 | $1.4B | -$149.5M | -$0.08 | -$69.2M | -9.0% | 2741.4% |
| FY2021 | $1.2B | -$195.3M | -$0.11 | — | -15.3% | 1452.9% |
| FY2020 | $955.4M | -$22.9M | -$0.01 | — | -0.6% | 24.1% |
| FY2019 | $754.0M | -$44.7M | — | — | -3.9% | 52.5% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Alignment Healthcare, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Alignment Healthcare, Inc. has historically struggled to out-earn its cost of capital, averaging just 3.4% ROIC.
Alignment Healthcare, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Alignment Healthcare, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.00 per share.